Latest total assets for 6848.TWO: $730M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), 6848.TWO shows a total assets of $730M. That compares with $760M in the prior-year period — down 4.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 6848.TWO's total assets is now $730M (was $760M) — a 4.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether RBC Bioscience is outperforming or lagging.
Tracking 6848.TWO's total assets over time shows whether RBC Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $730M That compares with $760M in the prior-year period — down 4.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has RBC Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $730M) with ownership activity and broader fundamentals.
RBC Bioscience's total assets is $730M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.